Company sells 4,158,750 common shares at $10.00 per share through deal
By Devika Patel
Knoxville, Tenn., March 17 – Ignyta, Inc. arranged and completed a $41.59 million registered direct offering of shares on March 17, according to a prospectus supplement and 8-K filed Tuesday with the Securities and Exchange Commission.
The company sold 4,158,750 common shares at $10.00 per share. The price per share is a 33.33% premium to the March 16 closing share price of $7.50.
Proceeds will be used for research and development activities, working capital and general corporate purposes.
The drug development company is based in San Diego.
| Issuer: | Ignyta, Inc.
|
| Issue: | Common shares
|
| Amount: | $41,587,500
|
| Shares: | 4,158,750
|
| Price: | $10.00
|
| Warrants: | No
|
| Pricing date: | March 17
|
| Settlement date: | March 17
|
| Stock symbol: | Nasdaq: RXDX
|
| Stock price: | $7.50 at close March 16
|
| Market capitalization: | $155.11 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
